Clinical Trial Update: NOX-E36 in Patients With Type 2 Diabetes Mellitus and Albuminuria [Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 2 clinical trial of NOX-E36 in patients with type 2 diabetes mellitus and albuminuria.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Albuminuria
• Type 2 Diabetes Mellitus

Drugs mentioned

• NOX-E36

Snippet

Sponsor: TME Pharma AG | Conditions: Type 2 Diabetes Mellitus, Albuminuria | Phase 2 | Status: COMPLETED